Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pradere

Showing results (351-360 of 412) with videos related to

Pageof 42
Sort By:
Arab Journal of Urology|March 25, 2021
Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysisMarco Moschini, Stefania Zamboni, Luca Afferi, et al.
Minerva Urology and Nephrology|October 5, 2022
Management of the incidental adrenal mass, continued surveillance versus surgical excision: analysis of US claims data on contemporary socio-demographic predictors and perioperative outcomesFrancesco Del Giudice, Wansuk Kim, Shufeng Li, et al.
Journal of Endourology|September 12, 2024
Clinical Significance of Tumor Location for Ureteroscopic Tumor Grading in Upper Tract Urothelial CarcinomaSatoshi Katayama, Benjamin Pradere, Nico C Grossman, et al.
BJU International|May 22, 2025
Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre studyMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
European Urology Oncology|June 21, 2024
Clinical Validation of the Intermediate-risk Non-muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group CollaborationFrancesco Soria, Matteo Rosazza, Simone Livoti, et al.
BJU International|January 11, 2025
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group resultsPietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
European Urology Oncology|February 20, 2026
Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological OutcomesMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
Asian Journal of Andrology|March 24, 2022
Torsion of the spermatic cord in adults: a multicenter experience in adults with surgical exploration for acute scrotal pain with suspected testicular torsionVan Thi Dang, Benjamin Pradere, Anne Mauger de Varennes, et al.
The Journal of Urology|December 8, 2022
Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational StudyMaximilian Pallauf, David D'Andrea, Frederik König, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 9, 2022
Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomySatoshi Katayama, Benjamin Pradere, Nico C Grossman, et al.
Pageof 42

Showing results (351-360 of 412) with videos related to

Sort By:
Pageof 42
Arab Journal of Urology|March 25, 2021
Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysisMarco Moschini, Stefania Zamboni, Luca Afferi, et al.
Minerva Urology and Nephrology|October 5, 2022
Management of the incidental adrenal mass, continued surveillance versus surgical excision: analysis of US claims data on contemporary socio-demographic predictors and perioperative outcomesFrancesco Del Giudice, Wansuk Kim, Shufeng Li, et al.
Journal of Endourology|September 12, 2024
Clinical Significance of Tumor Location for Ureteroscopic Tumor Grading in Upper Tract Urothelial CarcinomaSatoshi Katayama, Benjamin Pradere, Nico C Grossman, et al.
BJU International|May 22, 2025
Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre studyMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
European Urology Oncology|June 21, 2024
Clinical Validation of the Intermediate-risk Non-muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group CollaborationFrancesco Soria, Matteo Rosazza, Simone Livoti, et al.
BJU International|January 11, 2025
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group resultsPietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
European Urology Oncology|February 20, 2026
Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological OutcomesMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
Asian Journal of Andrology|March 24, 2022
Torsion of the spermatic cord in adults: a multicenter experience in adults with surgical exploration for acute scrotal pain with suspected testicular torsionVan Thi Dang, Benjamin Pradere, Anne Mauger de Varennes, et al.
The Journal of Urology|December 8, 2022
Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational StudyMaximilian Pallauf, David D'Andrea, Frederik König, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 9, 2022
Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomySatoshi Katayama, Benjamin Pradere, Nico C Grossman, et al.
Pageof 42